Cargando…

Cancer Cell Models for the Development of Anti-Cancer Drugs

Detalles Bibliográficos
Autor principal:	Telang, Nitin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699439/ https://www.ncbi.nlm.nih.gov/pubmed/36430932 http://dx.doi.org/10.3390/ijms232214457

Ejemplares similares

Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery
por: Telang, Nitin T.
Publicado: (2022)

Stem Cell Models for Cancer Therapy
por: Telang, Nitin
Publicado: (2022)

Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy
por: Telang, Nitin
Publicado: (2022)

Isolation and Characterization of Chemo-Resistant Stem Cells from a Mouse Model of Hereditary Non-Polyposis Colon Cancer
por: Telang, Nitin
Publicado: (2021)

The Divergent Effects of Ovarian Steroid Hormones in the MCF-7 Model for Luminal A Breast Cancer: Mechanistic Leads for Therapy
por: Telang, Nitin T.
Publicado: (2022)

Anti-Cancer Drug Design
por: Moore, Michael
Publicado: (1985)

Anthelmintics as Potential Anti-Cancer Drugs?
por: Heo, Dae Seog
Publicado: (2020)

Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer
por: Telang, Nitin T., et al.
Publicado: (2021)

Carcinogenesis: The more we seek to know the more we need to know – Challenges in the post Genomic Era
por: Kovvali, Gopala, et al.
Publicado: (2003)

Cancer drug development yesterday, today and tomorrow
por: Izbicka, Elzbieta, et al.
Publicado: (2023)

Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
por: Cicenas, Jonas, et al.
Publicado: (2021)

Translational research in anti-pancreatic fibrosis drug discovery and development
por: Ze, Xingyu, et al.
Publicado: (2021)

Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?
por: Abdollahi, Mohammad, et al.
Publicado: (2012)

Combination drug development in BRAF mutant colorectal cancer
por: Lam, Michael, et al.
Publicado: (2018)

DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?
por: Patel, Monal, et al.
Publicado: (2023)

Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
por: Jo, Yeonho, et al.
Publicado: (2018)

Mechanisms of Phytochemicals in Anti-Inflammatory and Anti-Cancer
por: Jang, Ji-Hoon, et al.
Publicado: (2023)

Bladder cancer — When will the paradigm change?
por: Kekre, Nitin S.
Publicado: (2011)

Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”
por: Sarkadi, Balázs
Publicado: (2023)

Drug Safety - Case Reports
por: Joshi, Nitin, et al.
Publicado: (2014)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

I-SPY 2: optimising cancer drug development in the 21st century
por: Bartsch, Rupert, et al.
Publicado: (2016)

Bladder cancer: Need for a standardized protocol of management
por: Kekre, Nitin S.
Publicado: (2008)

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”
por: Martínez-Campa, Carlos, et al.
Publicado: (2020)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

Anti-Epileptic Drug Toxicity in Children
por: Choonara, Imti
Publicado: (2018)

Biguanides and targeted anti-cancer treatments
por: Hanly, Elyse K., et al.
Publicado: (2015)

Hyperthermia-Based Anti-Cancer Treatments
por: Crezee, Johannes, et al.
Publicado: (2021)

Access to Cancer Drugs in Canada
por: Wheatley-Price, Paul
Publicado: (2022)

“Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue
por: Mini, Enrico, et al.
Publicado: (2020)

Celebrating novel cancer drugs
por: Weiss, Robin A
Publicado: (2003)

Drug dependence: Cancer medicine
por: Damle, S. G.
Publicado: (2013)

Immune checkpoint inhibitors for non-small cell lung cancer patients on steroid or non-steroidal anti-inflammatory drugs treatment—therapeutic indication or therapeutic efficacy?
por: Kawase, Akikazu
Publicado: (2022)

Neutrophils and anti-cancer immunity: a paradigm shift in cancer immunotherapy
por: Sturey, Rebecca, et al.
Publicado: (2017)

Medicinal Chemistry of Novel Anti-Diabetic Drugs
por: Adeghate, Ernest
Publicado: (2011)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
por: Shaik, Abdul Naveed, et al.
Publicado: (2019)

Advances in cancer therapy: clinical benefit of new cancer drugs
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Targeting the protein kinases for anti-cancer therapy
por: Bang, Soo-Mee
Publicado: (2012)

Cell cultures in drug development: Applications, challenges and limitations
por: Ghanemi, Abdelaziz
Publicado: (2015)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8courc6s28c1pfe4hvrrcel0jj